未登录

W

Weixia Xu

xia men university

H指数:11

被引数:323

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment

JOURNAL OF CONTROLLED RELEASE

IF11.5

2024-05-014

PRE

Influence of lung cancer model characteristics on tumor targeting behavior of nanodrugs

JOURNAL OF CONTROLLED RELEASE

IF11.5

2023-02-0111

PRE

All-stage targeted therapy for the brain metastasis from triple-negative breast cancer

三阴性乳腺癌脑转移的全阶段靶向治疗

ACTA PHARMACEUTICA SINICA B

IF14.6

2023-01-017

OAAI

In vivo self-assembled drug nanocrystals for metastatic breast cancer all-stage targeted therapy

体内自组装药物纳米晶体用于转移性乳腺癌全阶段靶向治疗

JOURNAL OF CONTROLLED RELEASE

IF11.5

2022-06-0116

PRE

All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals

JOURNAL OF CONTROLLED RELEASE

IF11.5

2022-05-0121

PRE

Impact of macroporous silica nanoparticles at sub-50nm on bio-behaviors and biosafety in drug-resistant cancer models

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2021-10-017

PREAI

Enhanced cancer therapy of celastrol in vitro and in vivo by smart dendrimers delivery with specificity and biosafety

CHEMICAL ENGINEERING JOURNAL

IF13.2

2020-03-0140

PREAI

Macroporous organosilicon nanocomposites co-deliver Bcl2-converting peptide and chemotherapeutic agent for synergistic treatment against multidrug resistant cancer

IF10.1

2020-01-0123

PREAI

Dendrimer-like mesoporous silica nanospheres with suitable surface functionality to combat the multidrug resistance

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2018-12-0111

PREAI

Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells

JOURNAL OF COLLOID AND INTERFACE SCIENCE

IF9.7

2018-10-0118

PREAI